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Objective: To evaluate the progression of carotid intima-media thickness (IMT) in the common carotid
artery (CCA) and the bifurcation over a mean follow-up of 16 years in relation to cardiovascular risk
factors.
Methods: The study population included 3426 middle-aged Swedish men and women participating in
the 1991e1994 (baseline) and the 2007e2012 (re-examination) investigation of the cardiovascular
cohort of the Malm€o Diet and Cancer Study (MDCS).
Results: There were differences in risk factor patterns in arterial segments in that diabetes and male sex
were associated with the progression of IMT in the bifurcation, but not in the CCA, and high-density
lipoprotein cholesterol (HDL) was associated with the progression of IMT in the CCA, but not in the
bifurcation. Favourable changes in systolic blood pressure (SBP), low-density lipoprotein cholesterol
(LDL) and HDL during follow-up decreased the IMT progression rate in the CCA. There was a cumulative
relationship between traditional cardiovascular risk factors (i.e., regular smoking, LDL/HDL-ratio  3,
hypertension) and IMT progression rates. The odds ratio (OR) of high IMT CCA progression rate (>75th
percentile) was 1.0 (reference), 1.4 (95% CI: 1.1, 1.7), 1.7 (95% CI: 1.3, 2.2) and 2.1 (95% CI: 1.4, 3.1),
respectively, for individuals with none, one, two, and three risk factors.
Conclusion: There were differences in the associations between risk factors and progression rate in
different arterial segments. Favourable changes in SBP and lipids during the follow-up period were
associated with reduced IMT progression rates in the CCA.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The atherosclerotic disease process is known to begin in child-
hood [1]. It develops during the life-course with the onset of car-
diovascular symptoms usually in late middle age. The long “silent”
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Ireland Ltd. This is an open accessmajor complications, such as harm to the heart or brain, have
occurred.
Prevention of cardiovascular disease has focused primarily on
strategies directed towards risk factors known to be related to
clinical events. However, in order to understand which factors play
a role in the earlier and later stages of atherosclerotic disease, it is
important to differentiate risk factors associated with the pro-
gression of atherosclerosis from those associated with plaque
rupture or thrombus formation. In recent years high-resolution B-
mode ultrasonography has been shown in large populations to be a
valid non-invasive method of monitoring atherosclerotic changes
such as progression of intima-media thickness (IMT) and increased
plaque burden in the carotid arteries. The value of carotid IMT as a
surrogate end-point in intervention or observational studies as an
alternative to cardiovascular disease (CVD) or death is strengthened
by its associations with risk factors [2e4] and coronary or cere-
brovascular events [5e15]. Recent studies, however, have shown
only small improvements in the risk prediction of cardiovasculararticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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gression of carotid IMT has been shown to be associated with
increased risk of cardiovascular events [18,19], although some
studies failed to show an association [20].
Since atherosclerosis progresses across decades, single mea-
surements of cardiovascular risk factors at the time of measure-
ment of carotid atherosclerosis, do not capture the impact of past
exposure to risk factors. During recent years longitudinal studies on
the association between risk factors and progression of carotid IMT
have evolved [21e30]. Most studies, however, do not separate such
associations between various segments of the carotid arteries, but
rather use composite measures of IMT even though crossesectional
associations with risk factors have been shown to differ across
various segments of the carotid wall [31e34]. Few studies have
investigated the importance of change in risk factor patterns at re-
examination after a long follow-up period.
The objective of the present study was to investigate the long-
eterm associations between baseline levels of traditional risk fac-
tors in the progression of IMT in the common carotid artery (CCA)
and in the bifurcation. In the analyses, we also investigated the
additive impact of various traditional cardiovascular risk factors on
IMT progression rates and speciﬁcally studied the importance of
changes in risk factor patterns on the carotid IMT progression rate.
2. Methods
2.1. Study population
The study population comprised men and women who partic-
ipated in the 1991e1994 (baseline) and the 2007e2012 (re-exam-
ination) investigation of the cardiovascular cohort of the Malm€o
Diet and Cancer Study (MDCS) [35,36]. All participants in the
baseline study (N ¼ 6103) who were alive and had not emigrated
from Sweden (N ¼ 4924) were invited to the re-examination,
including carotid ultrasound, from May 2007 to January 2012. A
total of 3734 subjects attended the follow-up investigation (76% of
the eligible population; Supplemental Fig. A). After the exclusion of
52 subjects with missing common carotid ultrasound data, 204
subjects with missing laboratory data, and 52 subjects with prev-
alent CVD, 1349 men and 2077 women were included in the pre-
sent study. Subjects were considered to have CVD if they had been
treated for myocardial infarction or stroke according to the national
and regional myocardial infarction or stroke register [37,38]. All
participants gave written informed consent. The Ethics Committee
at Lund University approved the study (LU 51-90 and LU
532e2006).
2.2. Baseline examination
Risk factors were estimated on the basis of laboratory tests,
physical examination, and a questionnaire administered at the
baseline visit. The self-administered questionnaire gathered data
about medical history, medical treatment, and smoking habits.
Details of assessment procedures have been previously reported
[39]. Regular smoking was assessed by questionnaire as the answer
“Yes, I smoke regularly” to the question: ”Do you smoke?” Supine
SBP was taken after 10 min of supine rest. Blood glucose, total
cholesterol and high-density lipoprotein cholesterol (HDL) were
measured according to standard procedures at the Department of
Clinical Chemistry, University Hospital Malm€o. Low-density lipo-
protein cholesterol (LDL) was calculated using Friedewald's for-
mula. Diabetes mellitus was identiﬁed through a self-reported
physician's diagnosis of diabetes, use of anti-diabetic medications
or a fasting blood glucose level 6.1 mmol/L. Fasting plasma sam-
ples were collected at the baseline examination, frozen and storedat 80 C. High-sensitive C-reactive protein (Hs-CPR) was analysed
from frozen samples using the Tina-quant® CRP latex high sensi-
tivity assay (Roche Diagnostics, Basel, Switzerland) on an ADVIA®
1650 Chemistry System (Bayer Healthcare, NY, USA). Study samples
were analysed as discrete samples and results were read in 6-s
intervals for 1 min following incubation for 5 min. The mean
value of these measurements was the result reported.
2.3. Follow-up examination
Similar to the baseline investigation, risk factors at follow-up
examinations were estimated on the basis of laboratory tests,
physical examination, and a questionnaire. Regular smoking was
assessed by questionnaire as the answer “Yes, I smoke regularly” to
the question: ”Do you smoke?” At the re-examination each subject
was seen by a nurse for measurement of height, weight and blood
pressure. Fasting blood was drawn for analysis of lipids and glucose
and aliquots were stored at minus 80. Blood pressure was
measured after 10 min rest in supine position. Plasma glucose was
measured using Hemocue (Hemocue, €Angelholm, Sweden). Total
and HDL-cholesterol were measured using standard procedures at
the Department of Clinical Chemistry, University Hospital Malm€o,
Sweden. LDL-cholesterol was calculated using Friedewald's
formula.
2.4. Carotid artery measurement
Carotid atherosclerosis was assessed with B-mode ultrasound
by specially trained and certiﬁed sonographers after completion of
an extensive training program [36,40]. The bifurcation area of the
right carotid artery was scanned for plaques, deﬁned as focal
thickening (>1.2 mm) of the arterial wall [41], within a pre-deﬁned
window encompassing 3 cm of the distal CCA, the bulb, and 1 cm
each of the internal and external carotid arteries. IMT was deter-
mined off-line in the far wall of the right distal CCA as the mean
thickness over a 10-mm segment proximal to the bifurcation ac-
cording to the leading edge principle. The leading edges of the
echoes representing the transitions between the lumen and the
intima layer and between the media and adventitia layers,
respectively, were outlined using a specially designed semi-
automatic computer-assisted analysing system [42]. The distances
between the two lines were measured at approximately 100 sites/
cm by the computer, and the mean value of these measurements
was calculated as IMTmean in the CCA. Maximum IMT in the far wall
of the bifurcation (i.e., the bulb) was also assessed. Such measure-
ments were initiated in February 1992, therefore only those
participating in MDCS between February 1992 and 1994 (n¼ 2837)
could be included in analyses of IMT in the bifurcation. Of these,
successful measurements of progression of IMT in the bifurcation
were taken in 2287 individuals. IMT in the internal carotid artery
was not speciﬁcally measured or analysed. Five sonographers per-
formed the IMT measurements at baseline and ﬁve at re-
examination. At regular intervals, intra- and interobserver varia-
tion analyses were performed with satisfactory results [39,43]. The
mean follow-up period was 16.6 (±1.5) years.
2.5. Statistics
Baseline cardiovascular risk factors among attendees and non-
attendees in re-examination were described by mean ± SD values
or by percentages. Differences in risk factors between attendees
and each of the three groups of non-attendees, were tested through
t tests for continuous data and c2 test for categorical data. Pro-
gression of carotid atherosclerosis was analysed by estimating the
annual change in mean IMT CCA and the maximum IMT in the
Table 1
Means (SD) and Prevalences (%) of Baseline Characteristics in 1991e1994 of attendees/non-attendees in the 2007e2012 Re-examination: The Malm€o Diet and Cancer study.
Attendees Non-attendees
Emigrated before
start of re-examination
Died before start of
re-examination
Non-attending due
to unwillingness,
sickness or lack of
information in registers
Men (n ¼ 1522; 59%) (n ¼ 65; 2%) (n ¼ 551; 21%) (n ¼ 434; 17%)
Age (Years) 56.3 ± 5.8 56.7 ± 6.1 60.3 ± 5.4a 58.3 ± 6.0a
Regular smoking (%) 18.7 28.8 36.8a 28.7a
Diabetes (%) 8.6 13.7 18.9a 16.3a
Systolic blood pressure (mmHg) 140.8 ± 17.4 140.7 ± 19.2 148.4 ± 20.8a 146.0 ± 18.3a
Antihypertensive treatment (%) 14.3 16.9 26.3a 16.1
BMI (kg/m2) 26.0 ± 3.2 26.6 ± 3.1 26.4 ± 4.0a 26.8 ± 3.8a
LDL-cholesterol (mmol/L) 4.14 ± 0.9 4.06 ± 0.9 4.09 ± 1.0 4.08 ± 0.9
HDL-cholesterol (mmol/L) 1.22 ± 0.3 1.19 ± 0.3 1.17 ± 0.3a 1.19 ± 0.3
Lipid-lowering treatment (%) 2.4 1.5 3.8 3.7
CRP (mg/L) 2.2 ± 3.5 2.3 ± 3.7 3.9 ± 6.5a 3.0 ± 4.6a
IMT CCA (mm) 0.77 ± 0.16 0.78 ± 0.19 0.84 ± 0.21a 0.82 ± 0.18a
IMT BIF (mm) 1.46 ± 0.62 1.49 ± 0.64 1.74 ± 0.75a 1.57 ± 0.65a
Women (n ¼ 2212; 63%) (n ¼ 78; 2%) (n ¼ 485; 14%) (n ¼ 756; 21%)
Age (Years) 56.3 ± 5.6 54.7 ± 6.2a 60.5 ± 5.4a 59.1 ± 5.9a
Regular smoking (%) 18.5 21.4 35.3a 27.2a
Diabetes (%) 4.6 3.1 12.9a 8.8a
Systolic blood pressure (mmHg) 137.5 ± 18.3 134.9 ± 18.2 145.7 ± 20.6a 143.9 ± 20.0a
Antihypertensive treatment (%) 13.1 11.5 20.0a 19.0a
BMI (kg/m2) 25.2 ± 3.9 24.8 ± 4.2 26.0 ± 4.4a 26.4 ± 4.9a
LDL-cholesterol (mmol/L) 4.13 ± 1.0 3.93 ± 1.1 4.33 ± 1.1a 4.36 ± 1.0a
HDL-cholesterol (mmol/L) 1.53 ± 0.4 1.54 ± 0.3 1.44 ± 0.4a 1.45 ± 0.4a
Lipid-lowering treatment (%) 1.5 0 2.5 2.4
CRP (mg/L) 2.2 ± 3.7 1.8 ± 1.9 3.6 ± 5.5a 3.0 ± 5.1a
IMT CCA (mm) 0.74 ± 0.13 0.73 ± 0.12 0.79 ± 0.17a 0.76 ± 0.13a
IMT BIF (mm) 1.35 ± 0.55 1.30 ± 0.62 1.53 ± 0.63a 1.46 ± 0.62a
BMI, body mass index; LDL-cholesterol, low-density lipoprotein cholesterol; HDL-cholesterol, high-density lipoprotein cholesterol; CRP, C-reactive protein; IMT, intimamedia
thickness; CCA, common carotid artery.
a Statistically signiﬁcantly different from attendees (p < 0.05).
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sociations between risk factors and IMT progression rate. Each
multiple linear-regression model of progression rate included the
following independent variables from the baseline investigation:
age, sex, BMI, presence of diabetes, SBP, antihypertensive treat-
ment, lipid-lowering treatment, LDL-cholesterol, HDL-cholesterol,
log transformed CRP, and smoking status (regular smoking yes/no).
These models were also adjusted for baseline IMT in the CCA and
the bifurcation, respectively. Analyses were also performed
excluding thosewith IMTmean CCA >1.2mm (the cut-off value in the
deﬁnition of carotid plaque) for progression rates of IMTmean CCA.
Age, BMI, SBP, LDL-cholesterol, HDL-cholesterol, log-transformed
CRP, baseline IMT in CCA and IMT in the bifurcation were ﬁtted as
continuous variables. Sex, smoking, diabetes, antihypertensive
treatment, and lipid-lowering treatment, were ﬁtted as dichoto-
mous variables. Similar analyses were performed using logistic
regression models categorizing IMTmean CCA and IMTmax bifurca-
tion progression rates into high and intermediate/low at the 75th
percentile. This cut-off was chosen based on results from previous
studies pointing to highly increased risk of future cardiovascular
events when progression rates exceed the 75th percentile [19].
Changes in SBP, LDL-cholesterol, HDL-cholesterol between baseline
examination and re-examination were categorized as having
similar, lower or higher values of SBP, LDL-cholesterol or HDL-
cholesterol, respectively, at re-examination compared to baseline.
Since very few subjects had zero change in risk factors between the
two examinations, we used subjects with similar risk factor levels
(the 20% of the subjects closest to zero change) as the reference
groups in the analyses of risk factor change. Accordingly similar SBP
at both examinations was deﬁned as a difference between e 5 mm
Hg and þ5 mmHg between the examinations. Similar HDL was
deﬁned as a difference between 0.07 and þ0.07 mmol/L andsimilar LDL was between 0.3 and þ0.3 mmol/L. These categories
were then analysed for the progression of mean IMT CCA and max
IMT in the bifurcation, respectively, using linear regression models
adjusting for age, sex, baseline IMT and baseline SBP, LDL-
cholesterol and HDL-cholesterol, respectively. Additional adjust-
ments were also made for blood pressure and lipid lowering
treatments at baseline and re-examination.
3. Results
The participant rate at re-examination was 76% (Supplemental
Figure A). Table 1 shows baseline characteristics among attendees
and non-attendees at the re-examination. As expected, non-
attendees at the re-examination generally had a worse risk factor
proﬁle, than attendees.
3.1. Baseline risk factor levels and carotid IMT progression rates
The IMTmean in CCA progression rates was 0.011 mm/year for
men and 0.010 mm/year for women. The corresponding progres-
sion rates for IMTmax in the bifurcation were 0.036 mm/year for
men and 0.030 mm/year for women.
3.1.1. IMT common carotid artery
Table 2 shows the associations between baseline risk factors and
progression of IMTmean in the CCA. Age, LDL-cholesterol, SBP, and
smoking were signiﬁcantly associated with increased progression
rate of IMTmean CCA, while HDL-cholesterol showed a negative
association. After excluding those with IMTmean CCA above 1.2 mm
at baseline or re-examination most of these risk factors were still
signiﬁcantly associated with the progression of IMTmean CCA, but
LDL-cholesterol was not (data not shown). Categorizing IMTmean
Table 3
Mutually Adjusted Effects of Baseline Risk factors on Progression Rate of Maximum
Intima-media Thickness (IMT) in the Carotid Bifurcation (mm/year) per Unit or
Category of each Risk Factor. Data from theMalm€o Diet and Cancer Study 1991e1994
(baseline examination) and 2007e2012 (re-examination).
Progression of IMT bifurcationmax
Difference 95% CI P
Age (Years) 0.0006 0.0003, 0.0010 <0.001
Male sex 0.006 0.002, 0.011 0.002
Regular smoking 0.009 0.005, 0.014 <0.001
Diabetes 0.009 0.001, 0.017 0.030
Systolic blood pressure (mmHg) 0.0003 0.0002, 0.0004 <0.001
Antihypertensive treatment 0.001  0.005, 0.007 0.70
BMI (kg/m2) 0.0001  0.0005, 0.0010 0.68
LDL-cholesterol (mmol/L) 0.003 0.001, 0.005 0.002
HDL-cholesterol (mmol/L)  0.004  0.009, 0.002 0.16
Lipid-lowering treatment 0.003  0.011, 0.016 0.72
Log CRP (mg/L) 0.002  0.002, 0.007 0.24
BMI, body mass index; LDL-cholesterol, low-density lipoprotein cholesterol; HDL-
cholesterol, high-density lipoprotein cholesterol; CRP, C-reactive protein.
Fig. 2. Differences in progression of intima-media thickness (IMT) in the common
carotid artery (CCA) (mm/year) by change in systolic blood pressure (SBP) between re-
examination and baseline investigation. Those with a change in SBP of ±5 mmHg
between re-examination and baseline investigation were used as the reference group.
Adjusted for age, sex, baseline IMT CCA and baseline SBP. Data from the Malm€o Diet
and Cancer Study, 1991e1994 (baseline examination) and 2007e2012 (re-
examination).
Table 2
Mutually Adjusted Effects of Baseline Risk factors on Progression Rate of Mean
Intima-media Thickness (IMT) in the Common Carotid Artery (mm/year) per Unit or
Category of Each Risk Factor. Data from theMalm€o Diet and Cancer Study 1991e1994
(baseline examination) and 2007e2012 (re-examination).
Progression of IMT CCAmean
Difference 95% CI P
Age (year) 0.00017 0.0001, 0.0002 <0.001
Male sex 0.0005  0.0003, 0.0014 0.22
Regular smoking 0.0020 0.0010, 0.0031 <0.001
Diabetes  0.0004  0.0022, 0.0012 0.58
Systolic blood pressure (mmHg) 0.00003 0.000004, 0.00005 0.022
Antihypertensive treatment  0.0011  0.0024, 0.0001 0.07
BMI (kg/m2) 0.00011  0.00001, 0.0002 0.07
LDL-cholesterol (mmol/L) 0.0006 0.0002, 0.0010 0.007
HDL-cholesterol (mmol/L)  0.0013  0.0025, 0.00008 0.037
Lipid-lowering treatment  0.0020  0.0051, 0.0010 0.19
Log CRP (mg/L) 0.0003  0.0006, 0.0013 0.55
BMI, body mass index; LDL-cholesterol, low-density lipoprotein cholesterol; HDL-
cholesterol, high-density lipoprotein cholesterol; CRP, C-reactive protein.
Fig. 1. Age, sex, and baseline IMT-adjusted odds ratios of high IMT CCA progression
rate (>75th percentile) among subjects with 0, 1, 2, and 3 risk factors. Risk factors were
hypertension (deﬁned as systolic blood pressure >140 mm Hg or diastolic blood
pressure >90 mm Hg or on antihypertensive treatment), LDL/HDL 3, and regular
smoking. Data from the Malm€o Diet and Cancer Study, 1991e1994 (baseline exami-
nation) and 2007e2012 (re-examination).
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percentile showed age- and smoking to be independent predictors
of a high progression rate, while HDL-cholesterol was negatively
associated with high progression (data not shown). The association
of LDL-cholesterol reached borderline statistical signiﬁcance
(p ¼ 0.05).
Baseline traditional risk factor levels (i.e., regular smoking, LDL/
HDL, hypertension) had a cumulative association with the pro-
gression rate of IMTmean CCA. Non-smokers, normotensives, and
those with LDL/HDL-ratio <3, were used as the reference group
(n ¼ 801). Having one risk factor (n ¼ 1350) was associated with an
increased annual progression rate, adjusted for age, sex- and
baseline IMT CCA, of 0.0015 mm (95% conﬁdence interval [CI]:
0.0005, 0.0025) compared with the reference category. Having two
(n ¼ 986) or all three (n ¼ 142) risk factors was associated with
increased progression rates of 0.0025 mm (95% CI: 0.0015 mm,
0.0036 mm) and 0.0034 mm (95% CI: 0.0014 mm, 0.0054 mm),
respectively. Fig. 1 shows a similar pattern of association for high
IMTmean CCA progression rate (>75th percentile). Non-smokers,
normotensives, and those with LDL/HDL<3, were used as refer-
ence. Having one risk factor was associated with an age, sex, and
baseline IMT CCA-adjusted odds ratio (OR) of 1.4 (95% CI: 1.1, 1.7) of
high progression rate compared with the reference category. Hav-
ing two or all three risk factors were associated with ORs of 1.7 (95%CI: 1.3, 2.2) and 2.1 (95% CI: 1.4, 3.1), respectively.
3.1.2. IMT bifurcation
Table 3 shows the associations between baseline risk factors and
progression rates of IMTmax in the bifurcation. Age, male sex, dia-
betes, LDL-cholesterol, SBP, and smoking were signiﬁcantly asso-
ciated with increased progression of maximum IMT in the
bifurcation. Categorizing progression rate of IMTmax in the bifur-
cation into high and intermediate/low at the 75th percentile
showed that all these factors were all also independent predictors
of such high progression rate (data not shown).
Similar to the progression of IMTmean CCA, there was a cumu-
lative association with baseline traditional risk factor levels (i.e.,
regular smoking, LDL/HDL-ratio  3, hypertension) on IMTmax
bifurcation progression rates. Having one versus none of these risk
factors was associated with an age, sex- and baseline IMTmax
bifurcation-adjusted OR of 1.4 (95% CI: 1.1, 1.9) for such a high
progression rate (Supplemental Figure B). Having two or all three
risk factors was associated with an OR of 1.9 (95% CI: 1.4, 2.5) or 3.0
(95% CI: 1.8, 4.8), respectively, for high progression rates
(Supplemental Figure B).
3.2. Change in risk factors
During the 16-year follow-up period there were important
changes in risk factor patterns. Such changes might affect carotid
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in the risk factors that showed signiﬁcant associations with
IMTmean CCA progression rate. Higher SBP at re-examination than
at baseline was associated with higher IMTmean CCA progression
rates than having a similar SBP at both examinations (difference:
±5mmHg (20% of the population) (reference group)) (Fig. 2), while
the opposite pattern was seen for having lower SBP at re-
examination than at baseline (Fig. 2). These associations were
adjusted for age, sex, baseline IMTmean CCA and baseline SBP.
Additional adjustment for antihypertensive treatments at baseline
and at re-examination did not change the associations (data not
shown). A similar association was seen for decreases in LDL-
cholesterol between baseline examination and re-examination af-
ter adjustment for age, sex, baseline IMTmean CCA and baseline LDL-
cholesterol. Those with a decrease in LDL-cholesterol of 0.3 mmol/L
or more between baseline and re-examination had a signiﬁcantly
lower IMTmean CCA progression rate than those with a similar LDL-
cholesterol at both examinations (difference: ± 0.3 mmol/L (20% of
the population) (reference group)). This association was reduced
and statistically non-signiﬁcant after further adjustment for lipid-
lowering treatment at baseline and at follow-up. Those with an
increase in LDL-cholesterol of 0.3 mmol/L or more did not show a
signiﬁcantly higher progression rate than the reference group (data
not shown). Those with an increase in HDL-cholesterol of more
than 0.07 mmol/L between baseline and re-examination had a
signiﬁcantly lower IMTmean CCA progression rate compared to
those with similar HDL-cholesterol at both examinations (differ-
ence: ±0.07 mmol/L d 20% of the population) (reference group),
while those with a decrease of HDL-cholesterol showed no signif-
icantly different progression rate than the reference group (data not
shown) after adjustment for age, sex, baseline IMTmean CCA and
baseline HDL-cholesterol. Additional adjustment for lipid lowering
treatments at baseline and at re-examination did not change the
associations (data not shown). Because very few non-smokers at
baseline started to smoke during follow-up (n < 15) similar ana-
lyses could not be performed for changes in smoking habits. Those
who were smokers at baseline and stopped smoking regularly
during follow-up showed no signiﬁcantly lower IMTmean CCA pro-
gression rate than those who were regular smokers at both in-
vestigations. Patterns of associations were generally weaker with
regard to progression of IMT in the bifurcation (data not shown).
4. Discussion
The results showed consistent associations between IMT pro-
gression rate, as assessed by a 16-year change in carotid IMT, and
the traditional risk factors smoking, blood lipids, and SBP.
Furthermore, there was a cumulative association between these
three risk factors and IMT progression rate. Having all three risk
factors was associated with doubled odds of high progression rate
of IMT CCA and tripled odds for high progression rate of IMT in the
bifurcation compared with those without such risk factors.
Although inﬂammatory mechanisms have been shown to be
important in the development and progression of atherosclerosis
[44], CRP showed no association with IMT progression rates in the
fully adjusted models.
Differences of risk factor patterns in arterial segments may be
connected to different clinical outcomes. However, segment-
speciﬁc differences in the associations between traditional risk
factors and the progression of carotid IMT have been very rarely
studied. In the present study, LDL-cholesterol, smoking and blood
pressurewere associated with IMT progression in both the CCA and
the bifurcation. There were also differences between the two seg-
ments in associations with risk factors. Diabetes and male sex were
associated with progression of IMT in the bifurcation, but not in theCCA, while the opposite pattern was seen for HDL-cholesterol.
Similar ﬁndings of stronger associations between diabetes and
IMT in the bulb than in the CCA have been shown in a population-
based cross-sectional study in young adults [31]. Another cross-
sectional study of middle-aged women showed positive associa-
tions between SBP, weight and both IMT in the CCA and the bulb,
while smoking showed an association only with IMT in the bulb
[34].
Favourable changes in risk factor levels during follow-up
seemed to decrease the IMT CCA progression rate. For example,
those with a decrease in SBP between baseline examination and re-
examination, had lower IMTmean CCA progression rates than those
with similar SBP at both examinations. A similar pattern of asso-
ciation was seen for changes in LDL-cholesterol and HDL-
cholesterol, but not for smoking cessation. Previously reported re-
sults from the population-based atherosclerosis risk in commu-
nities (ARIC) study showed associations between progression of
IMT CCA and changes in LDL cholesterol, HDL-cholesterol
(borderline signiﬁcance), triglycerides, onset of diabetes, and
onset of hypertension during a nine-year follow-up, while quitting
smoking versus continuing to smoke showed no such signiﬁcant
association [28]. These results support preventive strategies that
include risk factor interventions over the whole life-course since
reduced risk factor burden seems to slow atherosclerotic progres-
sion rates even in old age.
Previous studies have established that carotid IMT is associated
with the incidence of cardiovascular events. A meta-analysis
concluded that the age- and sex-adjusted relative risk of myocar-
dial infarction was 1.15 (95% CI, 1.12e1.17) and of stroke was 1.18
(95% CI, 1.16e1.21), respectively, per 0.10-mm IMT difference in the
CCA [5]. Furthermore, IMT changes over time have been associated
with incident stroke and myocardial infarction. A study by Polak
et al. showed that a yearly change of carotid IMT in the CCA
exceeding 0.0264 mm was associated with a more than two-fold
risk of incident stroke [19]. Another study by Hodis et al. showed
that for each 0.03-mm yearly increase in common carotid IMT, the
relative risk for nonfatal myocardial infarction or coronary death
increased more than twofold and the relative risk for a coronary
event was increased three-fold [45]. However, there are also
negative ﬁndings [20]. A recent meta-analysis failed to show an
association between progression of common carotid IMT and
increased risk of cardiovascular events [20]. Part of the explanation
might be attributed to methodological problems such as differ-
ences in ultrasound protocols, deﬁnitions of endpoints or duration
of clinical follow-up [20]. In the present study, IMT progression rate
was about 0.01 mm/year in the CCA and 0.03 mm/year in the
bifurcation. The clinical relevance of the ﬁndings has not yet been
evaluated due to too short follow-up after re-examination. How-
ever, in light of the abovementioned ﬁndings, also small differences
in IMT progression rate might be clinically relevant. Further studies
in this area are needed before the clinical relevance of the ﬁndings
can be established.
Certain methodological issues need to be addressed. Investi-
gating the progression of carotid atherosclerosis in a middle-aged
population is subject to methodological difﬁculties such as small
changes in IMT over time calling for long follow-up periods; po-
tential measurement errors of IMT; selective participation and
mortality; and changes in risk factor patterns and pharmacological
treatments over time. By using a long follow-up period (e.g., 16
years in the present study), regular ascertainment of a satisfactory
intra- and inter-observer variability, and collecting information on
changes in risk factor patterns and pharmacological treatments
during the follow-up period, we reduced these sources of error.
Many previous studies have used short follow-up periods, which
make it difﬁcult to measure low progression rates in healthy
M. Rosvall et al. / Atherosclerosis 239 (2015) 615e621620populations as a result of a healthy selection. Measurements of IMT
sometimes involve carotid plaques which make it difﬁcult to
discern whether risk factors are associated with a thickened IMT or
with the presence of plaque. However, this problem is likely
reducedwhenmeasuring IMT in the CCAwith low levels of plaques.
In the population-based ARIC study using the same age and sex
distribution as the present study, only 6% of white men and 3% of
white women, had plaque in the CCA [46]. When subjects with
carotid IMT in the CCA exceeding 1.2 mm were excluded, associa-
tions between baseline risk factors such as age, smoking, HDL-
cholesterol, and blood pressure and IMTmean CCA progression
rates were found to be similar to those in the whole population,
except for a weaker association with LDL-cholesterol. Changes in
risk factors during follow-up might be affected by regression to-
wards themean. To reduce such problems the analyses of change in
risk factor levels and progression rate were adjusted for baseline
measures. Those participating in the re-investigation were shown
to be healthier and to have more favourable cardiovascular risk
factor levels than non-participants. For example, participants
showed a lower risk of coronary events than non-participants over
the 16-year follow-up period, evenwhen thosewho died before the
start of re-examination were excluded (data not shown). Such a
healthy selection would, if anything, lead to a dilution of the true
associations between baseline risk factor levels and the progression
of atherosclerosis. Such selection seemed to bemore pronounced in
men than in women probably due to the fact that relatively more
men (21%) than women (14%) died before start of re-investigation.
The use of measures in the right carotid artery only might be a
limitation of this study and it is likely that measurements of both
sides would increase the precision. However, the prognostic sig-
niﬁcance of IMT in this study has been shown to be comparable to
results from studies that measured both sides [5]. In the present
study we focus on risk factor exposures in adult life, however, it is
well-known that the atherosclerotic disease process is life-long
where endothelial function and vascular morphology are affected
already in childhood [1,47].
In conclusion, traditional cardiovascular risk factors such as
smoking, blood lipids, and SBP were independently associated with
increased progression of carotid IMT, as assessed by a 16-year
follow-up of change in carotid IMT. There were differences in risk
factor patterns on arterial segments in that diabetes and male sex
were associated with progression of IMT in the bifurcation, but not
in the CCA, while the opposite pattern was seen for HDL-
cholesterol. Favourable changes in SBP and lipids during the
follow-up period seemed to decrease IMT progression rate in the
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